Animal Drug Compounding Market is Predicted to Reach USD 2.4 billion by 2031, Registering a 7.4% CAGR: TMR Report Wilmington, Delaware, United States, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The animal drug compounding market acquired US$ 1.1 billion in 2021. The market is likely...

Animal Drug Compounding Market is set to witness healthy growth at a CAGR of 8% over the forecast period of 2021-2031 NEW YORK, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Scarce availability of FDA-approved drug formulations for diseases in animals is mended through animal drug compounding, with varied formulations and...

Veterinary Drugs Market to reach US$ 27,570.0 Mn by 2025, at a CAGR of 5.6% | Exclusive Report by Fortune Business Insights Pune, June 19, 2019 (GLOBE NEWSWIRE) -- The rising demand for advanced drugs is likely to create lucrative growth opportunities for the global Veterinary Drugs Market, finds Fortune Business...

PetLife Pharmaceuticals Announces the Addition of Dr. Simon Wood PhD as the Company’s new Scientific Officer with plans to expand its Current Portfolio of Veterinarian Drugs and Nutraceuticals Hancock, MD, Oct. 19, 2016 (GLOBE NEWSWIRE) -- PetLife Pharmaceuticals, Inc. (OTC QB: PTLF) (the "Company"), a developer of a new generation of high potency veterinary cancer medications and...

PetLife Pharmaceuticals Continues Execution of its Vitalzul TM Business Plan with start of Proof of Concept studies; Provides Updates Hancock, MD, Sept. 14, 2016 (GLOBE NEWSWIRE) -- Hancock, MD - PetLife Pharmaceuticals, Inc. (OTC QB: PTLFD) (the "Company"), a developer of Vitalzul™, a new generation of high potency veterinary...